Indian Council of Agricultural Research-National Institute of High Security Animal Diseases (ICAR-NIHSAD) has transferred the first indigenous vaccine technology for the H9N2 avian influenza virus in chickens to to four private companies.
Key points
The vaccine will meet the standard of the market both in India and abroad. The vaccine will contribute significantly to increasing the income of poultry farmers by reducing the economic loss due to the disease.
Low Pathogenic Avian Influenza H9N2 Strain causes comorbidity in poultry flocks throughout the year, leading to huge economic losses to poultry farmers.
H9N2 Strain generally has a low mortality rate (up to 6 percent), but can increase significantly in the presence of other infections.
The disease could also lead to an irreversible egg production drop (up to 50 percent) in layer birds and a performance loss in broilers.
